Research Project
Grant-in-Aid for Challenging Exploratory Research
In this study, we developed an in vivo drug evaluation system that uses zebrafish as a tool for drug discovery for Diamond-Blackfan anemia (DBA). (1) We performed a compound screening as a pilot study to identify candidate drugs for DBA treatment. (2) A biolabeling method was developed to detect drug metabolism in vivo. (3) We used CRISPR-Cas9 system to generate DBA models that carry rps19 gene mutation. The rps19 homozygous mutants showed severe anemia at 48 hours post fertilization. (4) The toxicity test revealed an increased lethality depending on the time period of compound treatments.
All 2018 2017 2016 2015 Other
All Int'l Joint Research (1 results) Journal Article (1 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 1 results, Open Access: 1 results) Presentation (18 results) (of which Int'l Joint Research: 8 results) Remarks (2 results)
The Journal of Steroid Biochemistry and Molecular Biology
Volume: 174 Pages: 120-127
10.1016/j.jsbmb.2017.08.005
http://ribosome-labo.med.miyazaki-u.ac.jp
http://ribosome.med.miyazaki-u.ac.jp